Fundz

Cx Precision Medicine reported raising $1.22 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEDec 13, 2022

Amount Raised

$1.22 Million

$1.22 Million sold, per SEC Form D (first sale Dec 1, 2022)

Round Type

Seed

Forth WorthBiotechnologyHealthcare

Who to call at Cx Precision Medicine, Inc., and when

A new round usually means Cx Precision Medicine, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cx Precision Medicine, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cx Precision Medicine, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cx Precision Medicine, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cx Precision Medicine, Inc.

Location

1660 University Dr., #1216

Forth Worth, Texas, United States

About

Cx Precision Medicine is a life science company developing blood-based biomarker screening technology as well as companion diagnostics for therapeutic agents. Our lead products are focused on neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other dementia-causing disorders. Our low-cost and non-invasive tests will rule out Alzheimer’s disease and Parkinson’s disease for many and help identify others who will benefit from more comprehensive testing. Our test will also help physicians treat patients with the right medicines more quickly.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cx Precision Medicine, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Cx Precision Medicine, Inc.'s next move

See what Strategic adds

Cx Precision Medicine, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.